Tenaya Therapeutics, Inc. Quarterly Income Tax Expense (Benefit) in USD from Q2 2020 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Tenaya Therapeutics, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q2 2020 to Q1 2024.
  • Tenaya Therapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was $0.000.
  • Tenaya Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2023 was $0.000.
  • Tenaya Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2022 was $0.000.
  • Tenaya Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2021 was $0.000.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $0 $0 Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q1 2023 $0 $0 Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q1 2022 $0 $0 $0 Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $0 $0 Oct 1, 2021 Dec 31, 2021 10-K 2023-03-08
Q3 2021 $0 $0 Jul 1, 2021 Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $0 $0 Apr 1, 2021 Jun 30, 2021 10-Q 2021-09-08
Q1 2021 $0 Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q3 2020 $0 Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $0 Apr 1, 2020 Jun 30, 2020 10-Q 2021-09-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.